Publication Name	World Journal of Hepatology
Manuscript ID	14190
Country	South Korea

Received	2014-09-23 18:46
Peer-Review Started	2014-09-23 19:28
To Make the First Decision	2014-11-27 12:18
Return for Revision	2014-12-02 16:11
Revised	2015-02-12 17:27
Second Decision	2015-04-09 16:14
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-04-14 15:59
Articles in Press	2015-04-14 16:00
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-05-27 15:21
Publish the Manuscript Online	2015-06-16 14:22

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein
Manuscript Source	Invited Manuscript
All Author List	Su Jong Yu and Yoon Jun Kim
Funding Agency and Grant Number
Corresponding Author	Yoon Jun Kim, MD, Professor, Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, South Korea. yoonjun@snu.ac.kr
Key Words	Sorafenib; Hepatocellular carcinoma; Portal vein; Thrombosis
Core Tip	Given the modest survival gain and the limitation of sorafenib, such as resistance and tolerability, there are still clinical unmet needs in the management of patients with hepatocellular carcinoma (HCC) accom-panying portal vein tumor thrombosis (PVTT). Surgical resection-based multimodal treatments including liver transplantation and transarterial chemoembolization-based appropriate combination strategies for resectable HCC accompanying PVTT may improve overall survival in these patients.
Publish Date	2015-06-16 14:22
Citation	Yu SJ, Kim YJ. Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein. World J Hepatol 2015; 7(11): 1553-1561
URL	http://www.wjgnet.com/1948-5182/full/v7/i11/1553.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i11.1553

Full Article (PDF)	WJH-7-1553.pdf
Full Article (Word)	WJH-7-1553.doc
Manuscript File	14190-Review.doc
Answering Reviewers	14190-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	14190-Conflict-of-interest statement.pdf
Copyright License Agreement	14190-Copyright assignment.pdf
Peer-review Report	14190-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	14190-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	14190-Scientific misconduct check.pdf
Scientific Editor Work List	14190-Scientific editor work list.pdf